tiprankstipranks
Optiscan Unveils Game-Changing Telepathology Platform
Company Announcements

Optiscan Unveils Game-Changing Telepathology Platform

Optiscan Imaging Limited (AU:OIL) has released an update.

Pick the best stocks and maximize your portfolio:

Optiscan Imaging Ltd has announced the successful completion of their telepathology platform’s beta testing phase, in partnership with Prolucid Technologies. This innovative platform integrates Optiscan’s confocal imaging tech to enable real-time, remote collaboration for patient imaging, potentially revolutionizing digital pathology especially for remote areas. The company is now focused on developing a commercial version of the platform to enhance medical decision-making and patient care globally.

For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskOptiscan Imaging Advances in Digital Health Market
TipRanks Australian Auto-Generated NewsdeskOptiscan Imaging Partners with University for Veterinary Innovation
TipRanks Australian Auto-Generated NewsdeskOptiscan and Monash University Partner for AI-Powered GI Endoscope
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App